Doctor Wu

Xiao An Doctor

AI Smart Doctor, Guarding Your Health Every Day

ShuZhiHu AI
Scan QR code to consult Wang Junjie, MD

Scan with your phone to consult

Consult
Wang Junjie, MD
AI
Wang Junjie, MD
Chief physician

Proficient in the comprehensive treatment of lung cancer, liver cancer, pancreatic cancer, kidney cancer, and prostate cancer. Skilled in stereotactic radiotherapy (CyberKnife) and interventional minimally-invasive radioactive particle brachytherapy for tumors in the head and neck, chest, abdomen, pelvis, and soft tissues. Notably, the establishment of a standardized system for radioactive particle treatment technology and its popularization won the first-class award for scientific and technological progress in Beijing.

Director of Lanzhou Heavy Ion Cancer Center, Chairman of the Chinese Society of Radiotherapy and Oncology, First Chairman of the Chinese Nuclear Society's Close-proximity Therapy and Intelligent Radiotherapy Branch, Chairman of the 10th Committee of the Chinese Society of Radiotherapy and Oncology, Vice Chairman of the Chinese Anti-Cancer Association's Minimally Invasive Treatment Professional Committee, Chairman of the Radioactive Particle Ablation Technology Special Committee of the National Tumor Minimally Invasive Treatment Industry Innovation Strategic Alliance, Deputy Editor-in-Chief of the Chinese Journal of Radiological Medicine and Protection, Editorial Board Member of the American Brachytherapy Journal. Director of the Department of Radiation Oncology at Peking University Third Hospital, and a close-proximity treatment specialist at Peking University Medical School.

Chair of the Chinese Society for Radiation Oncology Chinese Medical Association
26 years
Experience
100%
Rating
250
Consultations
Scan QR code to consult Jörg Hauffe

Scan with your phone to consult

Consult
Jörg Hauffe
AI
Jörg Hauffe
Specially appointed expert

Specializes in the treatment of skull base tumors (such as chordomas, chondrosarcomas, etc.), liver cancer (including primary and metastatic liver cancer), lung cancer, pediatric tumors, and head and neck tumors.

CEO of the German PROHEALTH Medical Group, Director of the Munich Proton Therapy Center RPTC. After graduating from the Friedrich-Alexander University in Erlangen in 1993, he worked at the Institute of Physics at the University of Erlangen. During his time as a lecturer at the Erlangen Vocational School of Medical Technology, he conducted research at various accelerator facilities (including CERN in Geneva and the Jülich Research Centre), and also carried out fundamental research in proton therapy (radiobiology, radiometry), gaining extensive experience in basic research. In 1999, he organized the establishment of

Chief Executive Officer of PROHEALTH Medical Group GermanyMedical Director of the Rinecker Proton Therapy Center (RPTC) in Munich
33 years
Experience
100%
Rating
65
Consultations
Scan QR code to consult Tatsuaki Kanai

Scan with your phone to consult

Consult
Tatsuaki Kanai
AI
Tatsuaki Kanai
Specially appointed expert

Deputy Director of the Heavy Ion Line Center in Osaka, Japan, Guest professor of Gunma University, Distinguished Professor of Osaka University, member of the research team of Japan's first heavy ion device HIMAC, Director of the Department of Medical Physics of NIRS, Japan's National Institute of Radiological Medicine, Chief medical physicist of the Heavy Ion Hospital of Gunma University, Koya stage, doctoral supervisor of Gunma University.

Deputy Director of the Osaka Heavy Ion Line Sub-Center, Guest Professor at Gunma University, Distinguished Professor at Osaka University, and member of the research team that developed Japan's first heavy ion facility, HIMAC. He is also the Head of the Medical Physics Department at the National Institute of Radiological Sciences (NIRS), and the Chief Medical Physicist during the early phase of the Gunma University Heavy Ion Hospital. He is also a doctoral supervisor at Gunma University.

RadiotherapyDeputy Director of the Osaka Heavy Ion Therapy Center Japan
-
Experience
100%
Rating
17
Consultations
Scan QR code to consult Yee-Min Jen, MD, Ph.D.

Scan with your phone to consult

Consult
Yee-Min Jen, MD, Ph.D.
AI
Yee-Min Jen, MD, Ph.D.
Distinguished Professor

Radiotherapy 、 Radiation Therapy、Chemotherapy、Head and Neck Cancer、Esophageal Cancer、Stereotactic Ablative Radiotherapy (SABR)

Chief physician, professor, doctor of oncology, 9th chairman of the Taiwan Society of Radiation Oncology Current position: Special appointment professor at Wuwei Tumor Hospital, Gansu Province, vice president of Yiren Hospital, Taiwan, and part-time radiation oncology physician at National Defense Medical College, Tri-Service General Hospital. Published 68 SCI papers, including 25 first author or corresponding author papers and 36 core journal papers. Specialties: Radiotherapy, chemotherapy, head and neck cancer, esophageal cancer, stereotactic ablation radiotherapy, radiosurgery, palliative care for cancer, oncology teaching, medical education.

Chairman of the 9th Council of the Radiation Oncology Society of the Taiwan Region China
32 years
Experience
100%
Rating
26
Consultations
Scan QR code to consult Zhang Yanshan, MD

Scan with your phone to consult

Consult
Zhang Yanshan, MD
AI
Zhang Yanshan, MD
Chief physician II

Pioneered the "galloping scheme" for bladder cancer, first to apply High-Frequency Oscillatory Ventilation (HFOV) for respiratory motion control, and pioneered the surgical spacer technique.

Deputy Dean of Gansu Wuwei Tumor Hospital, Doctor, Visiting Researcher at the University of Chinese Academy of Sciences, Professor and Master's Supervisor at Gansu University of Chinese Medicine and Northwest Normal University, Leading Talent of Gansu Province, Excellent Expert of Gansu Province, Person in Charge of National Key Discipline Creation, First-Level Leading Talent of Wuwei City, Excellent Team of Provincial Department of Human Resources and Social Security, Excellent Team of Provincial Health Commission, Excellent Team of Provincial Federation of Trade Unions.

Vice President of Gansu Province Wuwei Tumor HospitalFounding Director of a National Key Discipline
-
Experience
100%
Rating
15
Consultations
Scan QR code to consult HIROHIKO TSUJII

Scan with your phone to consult

Consult
HIROHIKO TSUJII
AI
HIROHIKO TSUJII
Specially-engaged Expert

the vice president of QST Hospital (formerly NIRS) of the National Institutes for Quantum Science and Technology, concurrently the director of the International Treatment and Research Center, the president of the Japanese Radiation Oncology Society, the chairperson of the International Particle Therapy Collaboration Committee, and the president of the Japan Atomic Energy Association.

Vice President of QST Hospital (formerly NIRS), the National Research and Development Agency for Quantum Science and Technology; Director of the International Center for Therapeutic Research; President of the Japanese Society for Radiotherapy and Oncology; Chairman of the International Particle Therapy Cooperative Group; Chairman of the Japan Atomic Energy Promotion Foundation. In 1990, he became a Professor at the Department of Clinical Medicine, University of Tsukuba, and performed the world's first particle beam therapy for deep-seated tumors. He was named an Honorary Member of the European Society for Radiotherapy and Oncology (ESTRO) in 2001 and received the Takamatsu Kōhi Cancer Research Foundation Science Award and the NISTEP Science Award in 2005.

President of the Japanese Society for Radiation OncologyPerformed the first particle beam therapy for deep-seated tumors.
-
Experience
100%
Rating
14
Consultations
Scan QR code to consult Gyoergy Kovacs

Scan with your phone to consult

Consult
Gyoergy Kovacs
AI
Gyoergy Kovacs
Specially appointed expert

Specializing in Precision Radiotherapy for Breast Cancer, Prostate Cancer, etc.

Professor Emeritus, University of Lübeck, Germany Director of the Gemelli-INTERACTS Education Program at the Catholic University of the Sacred Heart, Italy Lifetime Achievement Award Winner of the European Society for Radiotherapy and Oncology (ESTRO) Honorary Member of Radiation Oncology Societies in Germany, Hungary, Belgium, India, and other countries Authoritative expert in the field of International Brachytherapy, specializing in precise radiotherapy for breast cancer, prostate cancer, etc.

Recipient of the ESTRO Lifetime Achievement AwardProfessor Emeritus at the University of Lübeck Germany
27 years
Experience
100%
Rating
2
Consultations

Latest News

20
2026.09

China's Heavy Ion Technology Birthplace Wuwei Makes Another Appearance in the Capital

After ten years of construction and six years of clinical practice, Wuwei Tumor Hospital in Gansu Province has delivered an inspiring "Chinese answer sheet." The Wuwei Heavy Ion Center was officially put into use in March 2020, and the Lanzhou Heavy Ion Center began to see patients in November 2024, forming a unique "one body with two wings" dual-center coordinated pattern of Wuwei and Lanzhou globally.

16
2026.09

China Carbon‑Ion Therapy International Symposium & Training Course (III) Held in Wuwei

On September 17, 2026, the International Training Program on Clinical Application of Carbon Ion Therapy System (Third Session) was launched at the Wuwei Heavy Ion Cancer Center. It gathers top experts from around the world to share the technological achievements and clinical standardization experiences of domestically developed heavy ion technology, promoting the high-quality development of heavy ion therapy.

11
2026.09

China's Heavy Ion Technology Shines at CIFTIS – A Destination for Cancer Patients Worldwide

In the golden autumn, we gather for a grand event, opening our doors to the future. The 2026 China International Fair for Trade in Services (CIFTIS) grandly opened in Beijing. At this year's fair, Gansu Province presents its exhibition under the theme "Symphony of the Silk Road, Auspicious Gansu," featuring the "Gansu Service Decoding Journey." The exhibition highlights four chapters of development: the journey of inheritance along a road, the journey of value‑added transformation of a kilowatt of electricity, the journey of sublimation of a single medicine, and the journey of transformation of a single letter.

03
2026.09

Heavy Ion & Nuclear Medicine Green Access Model Promotion Held in Dingxi

The 7th China (Gansu) Traditional Chinese Medicine Industry Expo is about to open in Longxi. To further amplify the brand impact of heavy ion therapy as a "national heavy instrument" and highlight Gansu's distinctive strengths in nuclear medicine, and in alignment with the province's integrated development strategy for biomedicine and nuclear medicine, Gansu Wuwei Cancer Hospital held a promotion conference on the high‑quality integrated development of heavy ion and nuclear medicine technologies and the green access medical model in Dingxi on September 2. The hospital will also feature a dedicated heavy ion exhibition at the 7th TCM Industry Expo. By integrating cutting‑edge heavy ion radiotherapy, targeted radionuclide therapy, and the rich advantages of traditional Chinese medicine resources in Gansu, the hospital aims to build a platform for promoting advanced cancer technologies, facilitate the distribution of high‑quality medical resources to the grassroots level, and support the

29
2026.08

Debuting in Beijing! China's Heavy Ion Technology Reaches the World

Debuting in the Capital! China's Heavy Ion Technology Goes Global. The Gansu Province Wuwei Tumor Hospital showcased domestic heavy ion technology in Beijing, highlighting breakthroughs and international achievements in precise tumor diagnosis and treatment, thereby contributing to "Healthy China" and the development of the Belt and Road Initiative.

logo

咨询